tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
3 Best Stocks to Buy Now, 9/23/2025, According to Top Analysts
PremiumMarket News3 Best Stocks to Buy Now, 9/23/2025, According to Top Analysts
15d ago
Global Expansion and Strategic Advancements Drive Buy Rating for ARS Pharmaceuticals
Premium
Ratings
Global Expansion and Strategic Advancements Drive Buy Rating for ARS Pharmaceuticals
19d ago
ARS Pharmaceuticals announces neffy approved in Japan
Premium
The Fly
ARS Pharmaceuticals announces neffy approved in Japan
19d ago
Short Report: C3.AI short positioning at 2025-high
PremiumThe FlyShort Report: C3.AI short positioning at 2025-high
1M ago
Ars Pharmaceuticals Reports Strong Q2 Growth and Global Expansion
Premium
Company Announcements
Ars Pharmaceuticals Reports Strong Q2 Growth and Global Expansion
1M ago
ARS Pharmaceuticals Faces Patent Challenge from Lupin
Premium
Company Announcements
ARS Pharmaceuticals Faces Patent Challenge from Lupin
1M ago
ARS Pharmaceuticals reports reports Q2 EPS (46c), consensus (51c)
PremiumThe FlyARS Pharmaceuticals reports reports Q2 EPS (46c), consensus (51c)
2M ago
Ars Pharmaceuticals, Inc. (SPRY) Q2 Earnings Cheat Sheet
Premium
Pre-Earnings
Ars Pharmaceuticals, Inc. (SPRY) Q2 Earnings Cheat Sheet
2M ago
ARS Pharmaceuticals announces UK MHRA approval of EURneffy
Premium
The Fly
ARS Pharmaceuticals announces UK MHRA approval of EURneffy
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100